Clinical Trial Update: Comparison of Two Identical NN1250 Formulations in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study in healthy volunteers comparing two identical NN1250 insulin formulations to evaluate pharmacokinetics and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes

Drugs mentioned

• NN1250

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED